Internal Medicine, Medical Oncology · Ocala, FL
NPI
1457396608
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2494 SW 19th Avenue Rd
Ocala, FL, 34471
Phone (352) 671-4422
Groups this clinician bills Medicare through
Medicare paid, 2024
$621K
123,779 services
Medicare patients, 2024
453
Average age 75
Drug cost, 2024
$4.9M
1,297 prescriptions
Company payments, 2025
$39.93
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi K Koti was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 16,830 times for 17 patients. In total Ravi K Koti billed 123,779 services in 61 codes, and Medicare paid $621K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 16,830 | 17 | $0.28 | $4,741 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,140 | 99 | $0.09 | $555 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 2,350 | 19 | $0.25 | $594 |
| J1750 Injection, iron dextran, 50 mg | Office | 1,734 | 73 | $13.72 | $24K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,430 | 18 | $5.83 | $8,330 |
| 36415 Venipuncture Blood Collection | Office | 1,401 | 346 | $4.90 | $6,860 |
| 85025 Blood Count | Office | 1,344 | 345 | $7.61 | $10K |
| 99213 Office E&M - Established | Office | 1,269 | 304 | $69.78 | $89K |
| 96375 Injection Administration | Office | 1,126 | 103 | $12.33 | $14K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 432 | 97 | $0.66 | $283 |
| 96365 Intravenous Infusion, Hydration | Office | 424 | 98 | $49.41 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 256 | 83 | $65.33 | $17K |
| 99214 Office E&M - Established | Office | 209 | 147 | $96.87 | $20K |
| 96413 Chemotherapy Administration | Office | 199 | 19 | $100.63 | $20K |
| 96372 Injection Administration | Office | 181 | 17 | $11.61 | $2,101 |
By year: 2022 $1.1M for 159,273 services; 2023 $812K for 140,671 services; 2024 $621K for 123,779 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,401 | 346 | $4.90 | $6,860 |
| 85025 Blood Count | 1,344 | 345 | $7.61 | $10K |
| 85610 Clinical Chemistry | 98 | 11 | $4.20 | $412 |
Medicare prescription drug claims, 2024
In 2024, the drug Ravi K Koti prescribed most often to Medicare patients was Eliquis (Apixaban), with 114 prescriptions and refills. In total Ravi K Koti wrote 1,297 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 114 | 162 | 41 | $92K |
| Anastrozole Generic | 98 | 182 | 28 | $1,633 |
| Hydroxyurea Generic | 63 | 81 | Under 11 | $772 |
| Xarelto Rivaroxaban | 62 | 76 | 15 | $41K |
| Dexamethasone Generic | 52 | 52 | 12 | $586 |
| Acyclovir Generic | 49 | 55 | Under 11 | $540 |
| Lenalidomide Generic | 44 | 44 | Under 11 | $541K |
| Ondansetron Odt Ondansetron | 43 | 49 | 40 | $2,198 |
| Zarxio Filgrastim-Sndz | 39 | 39 | Under 11 | $76K |
| Prochlorperazine Maleate Generic | 38 | 43 | 36 | $658 |
| Warfarin Sodium Generic | 37 | 49 | Under 11 | $119 |
| Prednisone Generic | 35 | 40 | Under 11 | $323 |
| Abiraterone Acetate Generic | 34 | 34 | Under 11 | $38K |
| Keytruda Pembrolizumab | 33 | 33 | Under 11 | $387K |
| Xgeva Denosumab | 30 | 45 | Under 11 | $98K |
Brand drugs: 657 claims; generic drugs: 640 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi K Koti $39.93 ($39.93 in general payments such as food, travel and fees) from 2 companies. The largest payer was ASD Specialty Healthcare, LLC with $24.68.
| Company | Payments | Amount |
|---|---|---|
| ASD Specialty Healthcare, LLC | 1 | $24.68 |
| Amgen Inc. AMGN | 1 | $15.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.